4-hydroxy-4,6-dihydrofuro[3,2-c]pyran-2-one

C1C=C2C(=CC(=O)O2)C(O1)O

InChI=1S/C7H6O4/c8-6-3-4-5(11-6)1-2-10-7(4)9/h1,3,7,9H,2H2

ZRWPUFFVAOMMNM-UHFFFAOYSA-N

patulin; 149-29-1; Clavacin; Clavatin; Expansin; Patuline; Expansine; Claviformin; Claviform; Clairformin; Leucopin; Terinin; Gigantin; Mycoin; Mycoin C3; Penicidin; Tercinin; Mycoine C3; Mycosin; Penatin; Mycoin C; 4-Hydroxy-4H-furo[3,2-c]pyran-2(6H)-one; 4-hydroxy-4,6-dihydrofuro[3,2-c]pyran-2-one; 4H-Furo[3,2-c]pyran-2(6H)-one, 4-hydroxy-; Sch-351633; NSC 8120; NSC 32951; 4-Hydroxy-4H-furo(3,2-C)pyran-2(6H)-one; 4H-Furo(3,2-c)pyran-2(6H)-one, 4-hydroxy-; (2,4-Dihydroxy-2H-pyran-3(6H)-ylidene)acetic acid, 3,4-lactone; 4,6-Dihydro-4-hydroxy-2H-furo(3,2-c)pyran-2-one; NSC8120; NSC32951; SCH 351633; (2,4-Dihydroxy-2H-pyran-3(6H)-ylidene)acetic acid-3,4-lactone; Acetic acid, (2,4-dihydroxy-2H-pyran-3(6H)-ylidene)-, 3,4-lactone; 4,6-dihydro-4-hydroxy-2H-furo[3,2-c]pyran-2-one; 95X2BV4W8R; CHEMBL294018; CHEBI:74926; NSC-8120; NSC-32951; (2, 3,4-lactone; 4-Hydroxy-4,6-dihydrofuro[4,5-c]pyran-2-one; 4H-Furo[3, 4-hydroxy-; 4-hydroxy-4,6-dihydro-2H-furo[3,2-c]pyran-2-one; 2,.alpha.-acetic acid, 3,4-lactone; Patulin 100 microg/mL in Acetonitrile; WLN: T56 BOV GO IU & TJ FQ; CCRIS 4940; HSDB 3522; SR-05000002238; EINECS 205-735-2; MFCD00005858; BRN 0149675; UNII-95X2BV4W8R; Clavicin; Clavitin; Expansion; 2H-Pyran-.delta.(sup 3(6H), 2,4-dihydroxy-, 3,4-lactone; Acetic acid,4-dihydroxy-2H-pyran-3(6H)-ylidene)-, 3,4-lactone; Gigantic acid?; 4H-Furo(3,3-c)pyran-2(6H)-one, 4-hydroxy-; DL-PATULIN; Patulin-[13C3]; Spectrum_000015; starbld0009637; Antibiotic YS 1649; PATULIN [HSDB]; PATULIN [IARC]; PATULIN [MI]; 2,4-Dihydroxy-2H-pyran-delta-3(6H),alpha-acetic acid-3,4-lactone; Spectrum3_000796; Spectrum4_000753; Spectrum5_001659; PATULIN 13C3; 2H-Pyran-delta(sup 3(6H),alpha)-acetic acid, 2,4-dihydroxy-, 3,4-lactone; Antibiotic Sch 351633; Patulin, reference material; Neuro_000008; Clairformin;Patuline;Clavatin; SCHEMBL29056; BSPBio_002532; KBioGR_001106; KBioSS_000355; 5-18-03-00005 (Beilstein Handbook Reference); DivK1c_000438; SPECTRUM1503904; MEGxm0_000442; DTXSID2021101; ACon1_002106; HMS501F20; KBio1_000438; KBio2_000355; KBio2_002923; KBio2_005491; KBio3_001752; NINDS_000438; HMS1923M19; Patulin, >=98.0% (HPLC); BCP29227; EX-A5478; HY-N6779; BDBM50158841; AKOS015904103; BS-1260; CCG-208451; DB15586; YS 1649; IDI1_000438; SMP1_000230; NCGC00095272-01; NCGC00095272-02; NCGC00095272-03; NCGC00095272-04; NCGC00095272-05; NCI60_041782; DB-042987; 4-Hydroxy-4H,6H-furo[3,2-c]pyran-2-one; CS-0083018; FT-0631849; FT-0673527; 4-Hydroxy-4H-Furo(3,3-c)pyran-2(6H)-one; 4-hydroxy-2H,4H,6H-furo[3,2-c]pyran-2-one; Q414526; J-008576; SR-05000002238-2; SR-05000002238-3; 2,4-Dihydroxy-2H-pyran-alpha -acetic acid, 3, 4-lactone; 4-Hydroxy-4H-furo[3,2-c]pyran-2(6H)-one, 9CI, 8CI; (+/-)-4-HYDROXY-4H-FURO(3,2-C)PYRAN-2(6H)-ONE; 2H-Pyran-.delta.(sup 3(6H), 2,4-dihydroxy-,3,4-lactone; 2H-Pyran-alpha )-acetic acid, 2, 4-dihydroxy-,3,4-lactone; 2H-Pyran-alpha )-acetic acid, 2,4-dihydroxy-, 3,4-lactone; 2,4-Dihydroxy-2H-pyran-.delta.-3(6H),.alpha.-acetic acid, 3,4-lactone; 2H-Pyran-.delta.(3(6H),.alpha.)-acetic acid, 2,4-dihydroxy-,3,4-lactone; 247172-18-5